Alvotech (ALVO), a commercial-stage global biotech company specializing in the development and manufacture of biosimilar medicines, ...
Alvotech announced its inclusion in the Nasdaq Biotechnology Index, effective December 23, 2024, as part of the index’s annual reconstitution. This inclusion is expected to enhance Alvotech’s ...
Alvotech, a biotech company focused on developing biosimilar medicines, announced its inclusion in the Nasdaq Biotechnology Index (NBI) as part of the index's annual reconstitution, effective ...